Literature DB >> 7688203

The ATP4- receptor-operated channel (P2Z class) of human lymphocytes allows Ba2+ and ethidium+ uptake: inhibition of fluxes by suramin.

J S Wiley1, R Chen, G P Jamieson.   

Abstract

It is now recognized that extracellular ATP can open a receptor-operated ion channel in a variety of cell types. In human lymphocytes this P2Z purinergic channel conducts Na+, K+, Rb+, Li+, and Ca2+ but its permeability to larger cations is not known. Fluorometric measurements were used to show that ATP4- induced the entry of Sr2+ (87 Da) and Ba2+ (137 Da) into human lymphocytes loaded with fura-2. Flow cytometry was used to show that ATP4- induced the entry of ethidium+ (314 Da) but that the larger propidium2+ cation (414 Da) was excluded. ATP(4-)-induced entry of both Ba2+ and ethidium+ showed features previously demonstrated for smaller cation permeants: (i) inhibition by amiloride analogs, (ii) sigmoid dependence of flux on ATP concentrations, and (iii) inhibition by extracellular Na+ ions. Specific inhibitors of L-type voltage-gated Ca2+ channels (nisoldipine and diltiazem) had no effect on ATP(4-)-induced Ba2+ influx. Suramin and reactive blue 2, which are recognized antagonists of ATP-operated purinergic receptors in other tissues, inhibited ATP-induced uptake of ethidium+ in lymphocytes with K1/2 of 61 and 69 microM, respectively. However, hexamethylene amiloride was a more potent inhibitor of ATP-induced ethidium+ uptake with a K1/2 of 13 microM. These data show that the ATP4- receptor-operated channel of human lymphocytes allows influx of cations as large as Ba2+ or ethidium+ and that this influx is inhibited by suramin and reactive blue 2.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7688203     DOI: 10.1006/abbi.1993.1392

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  30 in total

1.  P2X7 receptor activation mediates organic cation uptake into human myeloid leukaemic KG-1 cells.

Authors:  Safina Gadeock; Aleta Pupovac; Vanessa Sluyter; Mari Spildrejorde; Ronald Sluyter
Journal:  Purinergic Signal       Date:  2012-06-05       Impact factor: 3.765

2.  Functional characterisation of P2 purinoceptors in PC12 cells by measurement of radiolabelled calcium influx.

Authors:  A D Michel; C B Grahames; P P Humphrey
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-11       Impact factor: 3.000

3.  P2 receptor blockade attenuates fever and cytokine responses induced by lipopolysaccharide in rats.

Authors:  Alexander V Gourine; Dmitry M Poputnikov; Nikolai Zhernosek; Ekaterina V Melenchuk; Rüdiger Gerstberger; K Michael Spyer; Valery N Gourine
Journal:  Br J Pharmacol       Date:  2005-09       Impact factor: 8.739

4.  Selective permeabilization of cervical cancer cells to an ionic DNA-binding cytotoxin by activation of P2Y receptors.

Authors:  Maurish Bukhari; Han Deng; Noelle Jones; Zachary Towne; Craig D Woodworth; Damien S K Samways
Journal:  FEBS Lett       Date:  2015-05-01       Impact factor: 4.124

5.  An ATP-gated cation channel with some P2Z-like characteristics in gastric smooth muscle cells of toad.

Authors:  M Ugur; R M Drummond; H Zou; P Sheng; J J Singer; J V Walsh
Journal:  J Physiol       Date:  1997-01-15       Impact factor: 5.182

6.  The P2Z-purinoceptor of human lymphocytes: actions of nucleotide agonists and irreversible inhibition by oxidized ATP.

Authors:  J S Wiley; J R Chen; M B Snook; G P Jamieson
Journal:  Br J Pharmacol       Date:  1994-07       Impact factor: 8.739

7.  Fluorescent dyes as a reliable tool in P2X7 receptor-associated pore studies.

Authors:  Leonardo Ferreira; Luíza Pereira; Robson Faria
Journal:  J Bioenerg Biomembr       Date:  2015-06-16       Impact factor: 2.945

8.  Nonselective cationic currents elicited by extracellular ATP in human B-lymphocytes.

Authors:  F Bretschneider; M Klapperstück; M Löhn; F Markwardt
Journal:  Pflugers Arch       Date:  1995-03       Impact factor: 3.657

9.  P2 purinoceptor-activated inward currents in follicular oocytes of Xenopus laevis.

Authors:  B F King; S Wang; G Burnstock
Journal:  J Physiol       Date:  1996-07-01       Impact factor: 5.182

Review 10.  Recent patents on novel P2X(7) receptor antagonists and their potential for reducing central nervous system inflammation.

Authors:  Scott A Friedle; Marjorie A Curet; Jyoti J Watters
Journal:  Recent Pat CNS Drug Discov       Date:  2010-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.